Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trialâ€“Offering Treatment to New Ischemic Stroke Patient Population
apnews.com
science
2022-06-02 14:03:34

YOKNEAM, Israel & MIAMI--(BUSINESS WIRE)--Jun 2, 2022--Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. The trial is the first-ever FDA investigational device exemption (IDE) trial to examine the safety and effectiveness of mechanical thrombectomy in distal stroke.'Enrolling the first patient in this landmark study is an important milestone for patients,' says Dr. Hannes Nordmeyer, Neuroradiology Department head at radprax Neurocenter in Solingen, Germany.
